Our research group is dedicated to the investigation and development of bio-based and hybrid materials tailored for applications in wound care, tissue engineering, and the development of artificial tissues and organs.
A key emphasis is placed on the production of application-optimized biomaterials using state-of-the-art manufacturing technologies. We employ advanced techniques such as uni- and coaxial electrospinning, lyophilization, and 3D bioprinting. These innovative methods enable the processing of proteins, peptides, polysaccharides, and biocompatible polymers into nano- and microfibers, nonwovens, foams, hydrogels, and bio-inks, as well as into cell-seeded and acellular artificial tissues and organ models. By combining materials, processes, and manufacturing technologies – together with chemical or enzymatic cross-linking strategies – we enable precise tuning of microstructural, biochemical, physicochemical, and mechanical properties.
Our goal is to develop sustainable, high-performance biomaterials that not only meet current demands in medical research but also pave the way for future applications in regenerative medicine.